Latest Methicillin-resistant Staphylococcus aureus Stories
LONDON, Oct. 15, 30, 2014 /PRNewswire/ -- Infections from activities and procedures taking place within a healthcare facility have become a cause for great concern.
Hospital visitors and staff are greeted with hand sanitizer dispensers in the lobby, by the elevators and outside rooms as reminders to wash their hands to stop infections, but just how clean are patients' hands?
VIENNA and PHILADELPHIA, October 8, 2014 /PRNewswire/ -- Nabriva Therapeutics AG, a biotechnology company focused on developing pleuromutilins, a new class of antibiotics
LAUSANNE, Switzerland, October 7, 2014 /PRNewswire/ -- Debiopharm Group(TM)(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that
Topical report “Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014” worked out by Global Markets Direct is now available at MarketPublishers.com.
- Lead Product DALVANCE(TM) a Novel Antibiotic for Unmet Medical Need in Hospital and Outpatient Settings - DUBLIN, Ireland and CHICAGO, Oct.
Company Completes Enrollment in Phase 2 Clinical Trial AUSTIN, Texas, Oct.
ROUND ROCK, Texas, Oct.
CHICAGO, Oct. 1, 2014 /PRNewswire-USNewswire/ -- 'The MRSA Epidemic - A Call to Action' is this year's global theme.